InsightfulValue
← Home

Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical

Pharma / Pharmaceuticals and medical products manufacturing


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Hisamitsu Pharmaceutical

πŸ“Š Get full analytics about Hisamitsu Pharmaceutical

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Overview
Hisamitsu Pharmaceutical is a Japanese pharmaceutical company that specializes in developing and selling over-the-counter medications and medical devices. It was founded in 1847 and has its headquarters in Saga, Japan.
The company has a presence in over 80 countries, with subsidiaries and affiliates in Asia, Europe, North America, and Latin America. Its products are divided into three main categories: OTC products, Prescription products, and Medical Devices.
Some of the most well-known products manufactured by Hisamitsu Pharmaceutical include Salonpas, a pain relieving patch, and Mohrus, a motion sickness relief medication. The company also produces a range of other OTC medications for various health issues, such as cold and flu, digestive problems, and allergies.
Hisamitsu Pharmaceutical has a strong focus on research and development, with a dedicated team of scientists and researchers working to develop new and innovative products. The company also places a high emphasis on providing safe and effective treatments for patients, and as such, adheres to strict quality standards in the manufacturing and testing of its products.
In addition to its pharmaceutical business, Hisamitsu also has a division for medical devices, including adhesive tapes and bandages. These products are designed to provide support and pain relief for various body parts and conditions.
Overall, Hisamitsu Pharmaceutical is committed to improving the well-being of people worldwide through the development and sale of high-quality and innovative healthcare products.
What is special about the company?
Hisamitsu Pharmaceutical

πŸ“ˆ Want to read more about Hisamitsu Pharmaceutical?

Sign up for free or log in

πŸ’‘ Learn smarter stock picks with "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

MS4gRm91bm RlZCBieSBh IFNhbXVyYW k6IEhpc2Ft aXRzdSBQaG FybWFjZXV0 aWNhbCB3YX MgZm91bmRl ZCBpbiAxOD Q3IGJ5IFRh cm8gSGlzYW 1pdHN1LCBh IHNhbXVyYW kgZnJvbSB0 aGUgQWtpdG EgY2xhbi4g SGUgd2FzIG luc3BpcmVk IGJ5IHRyYW RpdGlvbmFs IEphcGFuZX NlIG1lZGlj aW5lIGFuZC BkZWNpZGVk IHRvIGRlZG ljYXRlIGhp cyBsaWZlIH RvIHByb2R1 Y2luZyBoaW doLXF1YWxp dHkgcGhhcm 1hY2V1dGlj YWxzLjxicj 4yLiBQaW9u ZWVycyBpbi B0cmFuc2Rl cm1hbCBkcn VnIGRlbGl2 ZXJ5OiBJbi B0aGUgMTk1 MHMsIEhpc2 FtaXRzdSBQ aGFybWFjZX V0aWNhbHMg YmVjYW1lIG 9uZSBvZiB0 aGUgZmlyc3 QgY29tcGFu aWVzIGluIH RoZSB3b3Js ZCB0byBkZX ZlbG9wIGFu ZCBjb21tZX JjaWFsaXpl IHRyYW5zZG VybWFsIGRy dWcgZGVsaX ZlcnkgdGVj aG5vbG9neS 4gVG9kYXks IHRoZXkgYX JlIGxlYWRl cnMgaW4gdG hpcyBmaWVs ZCBhbmQgaG F2ZSBkZXZl bG9wZWQgYS ByYW5nZSBv ZiBpbm5vdm F0aXZlIGFu ZCBlZmZlY3 RpdmUgdHJh bnNkZXJtYW wgcHJvZHVj dHMuPGJyPj MuIEZvY3Vz IG9uIG5hdH VyYWwgaW5n cmVkaWVudH M6IEhpc2Ft aXRzdSBQaG FybWFjZXV0 aWNhbHMgcG xhY2VzIGEg c3Ryb25nIG VtcGhhc2lz IG9uIHVzaW 5nIG5hdHVy YWwgaW5ncm VkaWVudHMg aW4gdGhlaX IgcHJvZHVj dHMuIFRoZX kgYmVsaWV2 ZSBpbiB0aG UgcG93ZXIg b2YgdHJhZG l0aW9uYWwg SmFwYW5lc2 UgbWVkaWNp bmUgYW5kIH VzZSBuYXR1 cmFsIGhlcm JhbCBleHRy YWN0cyBpbi B0aGVpciBw cm9kdWN0cy B3aGVuZXZl ciBwb3NzaW JsZS48YnI+ NC4gU3Ryb2 5nIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudDogVG hlIGNvbXBh bnkgZGV2b3 RlcyBhIHNp Z25pZmljYW 50IGFtb3Vu dCBvZiByZX NvdXJjZXMg dG8gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50LCB3 aXRoIGEgc3 Ryb25nIGZv Y3VzIG9uIG lubm92YXRp b24gYW5kIG ltcHJvdmlu ZyB0aGVpci Bwcm9kdWN0 cy4gVGhleS BoYXZlIGVz dGFibGlzaG VkIHBhcnRu ZXJzaGlwcy B3aXRoIGxl YWRpbmcgcm VzZWFyY2gg aW5zdGl0dX Rpb25zIGFu ZCB1bml2ZX JzaXRpZXMs IGFuZCB0aG VpciBwcm9k dWN0cyBhcm UgYmFja2Vk IGJ5IHNjaW VudGlmaWMg ZXZpZGVuY2 UuPGJyPjUu IEdsb2JhbC BwcmVzZW5j ZTogSGlzYW 1pdHN1IFBo YXJtYWNldX RpY2FsIGhh cyBhIHN0cm 9uZyBnbG9i YWwgcHJlc2 VuY2UsIHdp dGggb3Blcm F0aW9ucyBh bmQgcGFydG 5lcnNoaXBz IGluIG92ZX IgMjUgY291 bnRyaWVzLi BUaGlzIGFs bG93cyB0aG VtIHRvIHNo YXJlIHRoZW lyIGV4cGVy dGlzZSBhbm QgcHJvZHVj dHMgd2l0aC BhIHdpZGVy IG1hcmtldC 48YnI+Ni4g Q29tbWl0bW VudCB0byBo ZWFsdGggYW 5kIHdlbGxu ZXNzOiBIaX NhbWl0c3Ug UGhhcm1hY2 V1dGljYWxz IGlzIGRlZG ljYXRlZCB0 byBwcm9tb3 RpbmcgaGVh bHRoIGFuZC B3ZWxsbmVz cyBieSBkZX ZlbG9waW5n IHNhZmUgYW 5kIGVmZmVj dGl2ZSBwcm 9kdWN0cy4g VGhleSBhbH NvIGVuZ2Fn ZSBpbiB2YX Jpb3VzIHB1 YmxpYyBoZW FsdGggaW5p dGlhdGl2ZX MgdG8gZWR1 Y2F0ZSBhbm QgZW1wb3dl ciBwZW9wbG UgdG8gbWFr ZSBoZWFsdG hpZXIgY2hv aWNlcy48Yn I+Ny4gU29j aWFsIHJlc3 BvbnNpYmls aXR5OiBUaG UgY29tcGFu eSBpcyBjb2 1taXR0ZWQg dG8gc29jaW FsIGFuZCBl bnZpcm9ubW VudGFsIHJl c3BvbnNpYm lsaXR5LiBU aGV5IGhhdm UgaW1wbGVt ZW50ZWQgc3 VzdGFpbmFi bGUgcHJhY3 RpY2VzIGlu IHRoZWlyIH Byb2R1Y3Rp b24gcHJvY2 Vzc2VzIGFu ZCBoYXZlIG VzdGFibGlz aGVkIGEgZm 91bmRhdGlv biB0byBzdX Bwb3J0IHZh cmlvdXMgc2 9jaWFsIGNh dXNlcy48Yn I+OC4gUXVh bGl0eSBhbm Qgc2FmZXR5 IHN0YW5kYX JkczogSGlz YW1pdHN1IF BoYXJtYWNl dXRpY2Fscy BpcyBrbm93 biBmb3IgaX RzIHN0cmlj dCBxdWFsaX R5IGFuZCBz YWZldHkgc3 RhbmRhcmRz LiBUaGV5IH VzZSBhZHZh bmNlZCBtYW 51ZmFjdHVy aW5nIHByb2 Nlc3NlcyBh bmQgdGhlaX IgZmFjaWxp dGllcyBhcm UgcmVndWxh cmx5IGluc3 BlY3RlZCB0 byBlbnN1cm UgY29tcGxp YW5jZSB3aX RoIGludGVy bmF0aW9uYW wgc3RhbmRh cmRzLjxicj 45LiBEaXZl cnNlIHByb2 R1Y3QgcG9y dGZvbGlvOi BIaXNhbWl0 c3UgUGhhcm 1hY2V1dGlj YWxzIG9mZm VycyBhIGRp dmVyc2Ugcm FuZ2Ugb2Yg cHJvZHVjdH MsIGluY2x1 ZGluZyBwYW luIHJlbGll ZiBwYXRjaG VzLCBqb2lu dCBhbmQgbX VzY2xlIHBh aW4gcmVsaW VmIGNyZWFt cywgYW5kIG RpZ2VzdGl2 ZSBoZWFsdG ggc3VwcGxl bWVudHMuIF RoZXkgYWxz byBoYXZlIH Byb2R1Y3Rz IGZvciBza2 luY2FyZSwg Y2hpbGRjYX JlLCBhbmQg cGV0IGhlYW x0aGNhcmUu PGJyPjEwLi BTdHJvbmcg cmVwdXRhdG lvbjogSGlz YW1pdHN1IF BoYXJtYWNl dXRpY2FsIG hhcyBidWls dCBhIHN0cm 9uZyByZXB1 dGF0aW9uIG ZvciBkZWxp dmVyaW5nIG hpZ2gtcXVh bGl0eSBhbm QgZWZmZWN0 aXZlIHByb2 R1Y3RzLiBU aGVpciBkZW RpY2F0aW9u IHRvIGV4Y2 VsbGVuY2Ug aGFzIGVhcm 5lZCB0aGVt IHRoZSB0cn VzdCBvZiBo ZWFsdGhjYX JlIHByb2Zl c3Npb25hbH MgYW5kIGNv bnN1bWVycy Bhcm91bmQg dGhlIHdvcm xkLg==
What the company's business model?
Hisamitsu Pharmaceutical

πŸ“ˆ Want to read more about Hisamitsu Pharmaceutical?

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlIGJ1c2 luZXNzIG1v ZGVsIG9mIE hpc2FtaXRz dSBQaGFybW FjZXV0aWNh bCBpcyB0by ByZXNlYXJj aCwgZGV2ZW xvcCwgbWFu dWZhY3R1cm UsIGFuZCBt YXJrZXQgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMu IFRoZXkgcH JpbWFyaWx5 IGZvY3VzIG 9uIGRldmVs b3BpbmcgcH Jlc2NyaXB0 aW9uIGFuZC BvdmVyLXRo ZS1jb3VudG VyIG1lZGlj aW5lcywgbW VkaWNhbCBw YXRjaGVzLC BhbmQgb3Ro ZXIgaGVhbH RoIGNhcmUg cHJvZHVjdH MuIFRoZWly IGdvYWwgaX MgdG8gaW1w cm92ZSBwZW 9wbGXigJlz IGhlYWx0aC BhbmQgd2Vs bC1iZWluZy B0aHJvdWdo IHRoZWlyIH Byb2R1Y3Rz LiBUaGV5IG Fsc28gaGF2 ZSBhIHN0cm 9uZyBlbXBo YXNpcyBvbi BnbG9iYWxp emF0aW9uIG FuZCBleHBh bmRpbmcgaW 50byBvdmVy c2VhcyBtYX JrZXRzLiBU aGVpciBjb3 JlIGJ1c2lu ZXNzIHN0cm F0ZWd5IGlu Y2x1ZGVzIG NvbnRpbnVv dXMgaW5ub3 ZhdGlvbiwg c3RyYXRlZ2 ljIHBhcnRu ZXJzaGlwcy wgYW5kIGEg Y3VzdG9tZX ItY2VudHJp YyBhcHByb2 FjaC4gVGhl eSBhbHNvIH ByaW9yaXRp emUgc3VzdG FpbmFibGUg ZGV2ZWxvcG 1lbnQgYW5k IHNvY2lhbC ByZXNwb25z aWJpbGl0eS BpbiB0aGVp ciBidXNpbm VzcyBvcGVy YXRpb25zLg ==
Interesting facts about the company
Hisamitsu Pharmaceutical

πŸ“ˆ Want to read more about Hisamitsu Pharmaceutical?

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvS0 JPeGJMdmtK ZzN2eXFpQW NhcXkud2Vi cCIgYWx0PS JIaXNhbWl0 c3UgUGhhcm 1hY2V1dGlj YWwiIHRpdG xlPSJIaXNh bWl0c3UgUG hhcm1hY2V1 dGljYWwiIC BjbGFzcz0i aW1nLWZsdW lkIiBoZWln aHQ9OTAgd2 lkdGg9OTAg bG9hZGluZz 0nbGF6eScg c3R5bGU9J2 JvcmRlci1y YWRpdXM6ID ZweDsnPgoK ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdmbGV4Oi AxOyB0ZXh0 LWFsaWduOi BjZW50ZXI7 IG1hcmdpbi 1sZWZ0OiA1 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PHAgc3R5bG U9J2ZvbnQt c2l6ZTogMj ZweDsgY29s b3I6ICMzMz M7IG1hcmdp bi1ib3R0b2 06IDE1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IPCfk4ggV2 FudCB0byBy ZWFkIG1vcm UgYWJvdXQg SGlzYW1pdH N1IFBoYXJt YWNldXRpY2 FsPwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg4pqhIE luc3RhbnRs eSBhY2Nlc3 MgPGk+IlRo ZSBDaGVja2 xpc3QgVmFs dWUgSW52ZX N0b3Ig4oCU IEEgU21hcn RlciBXYXkg dG8gUGljay BTdG9ja3Mi PC9pPiDigJ QgZnJlZSEK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9wPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPCEtLQog ICAgICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdtYX JnaW4tdG9w OiAxMnB4Oy Bmb250LXNp emU6IDEzcH g7IGNvbG9y OiAjNDQ0Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IG5vdyBhbm QgZ2V0IG91 ciBmcmVlIG VCb29rIAog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGI+ VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr czwvYj4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IC0tPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID E2cHg7IGZv bnQtc2l6ZT ogMTRweDsg Y29sb3I6IC M0NDQ7IGZv bnQtZmFtaW x5OiAtYXBw bGUtc3lzdG VtLCBCbGlu a01hY1N5c3 RlbUZvbnQs IFNlZ29lIF VJLCBSb2Jv dG8sIEhlbH ZldGljYSBO ZXVlLCBzYW 5zLXNlcmlm OyBsaW5lLW hlaWdodDog MS42Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBIYX ZlIHlvdSBo ZWFyZCBhYm 91dCBvdXIg c2hvcnQgPH N0cm9uZyBz dHlsZT0nZm 9udC13ZWln aHQ6IDYwMD snPkRhaWx5 IFZpZGVvIE 5ld3NsZXR0 ZXI8L3N0cm 9uZz4/CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdodH RwczovL3d3 dy5pbnNpZ2 h0ZnVsdmFs dWUuY29tL2 5ld3NsZXR0 ZXIucGhwJy B0YXJnZXQ9 J19ibGFuay cgc3R5bGU9 J2NvbG9yOi AjMDA3QkZG OyB0ZXh0LW RlY29yYXRp b246IG5vbm U7IGZvbnQt d2VpZ2h0Oi A1MDA7IG1h cmdpbi1sZW Z0OiA2cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBGaW 5kIG91dCBt b3JlCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8L2E+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgCiAg ICAgICAgCi AgICAgICAg PHNwYW4gY2 xhc3M9J2Js dXJyZWQtdG V4dCc+CiAg ICAgICAgIC AgIE1TNGdT R2x6WVcgMX BkSE4xSUZC byBZWEp0WV dObGRYIFJw WTJGc0lFTn YgTGl3Z1NX NWpMaSBCcG N5QmhJRXBo IGNHRnVaWE 5sSUggQm9Z WEp0WVdObC BkWFJwWTJG c0lHIE52Yl hCaGJua2cg Wm05MWJtUm xaQyBCcGJp QXhPRFEzIE xqeGljajR5 TGkgQkpkQ0 JwY3lCMCBh R1VnYkdGeV oyIFZ6ZENC d2NtOWsgZF dObGNpQnZa aSBCMGNtRn VjMlJsIGNt MWhiQ0J3WV ggUmphR1Z6 SUdsdSBJSF JvWlNCM2Iz IEpzWkNCaG JtUWcgWVNC c1pXRmtaWC BJZ2FXNGdk R2hsIElHWn BaV3hrSUcg OW1JSEJvWV hKdCBZV05s ZFhScFkyIE ZzSUhSeVlX NXogWkdWeW JXRnNJRyBS bGJHbDJaWE o1IElITjVj M1JsYlggTX VQR0p5UGpN dSBJRWhwYz JGdGFYIFJ6 ZGVLQW1YTW cgWm14aFoz Tm9hWCBBZ2 NISnZaSFZq IGRDQnBjeU IwYUcgVWdV MkZzYjI1dy BZWE1nYkds dVpTIEJ2Wm lCd1lXbHUg SUhKbGJHbG xaaSBCd1lY UmphR1Z6IE xDQjNhR2xq YUMgQmhjbV VnYzI5cyBa Q0JwYmlCdm RtIFZ5SURV d0lHTnYgZF c1MGNtbGxj eSBCM2IzSn NaSGRwIFpH VXVQR0p5UG ogUXVJRlJv WlNCaiBiMj F3WVc1NUlH IGx6SUdobF lXUnggZFdG eWRHVnlaVy BRZ2FXNGdW Rzl6IGRTQk RhWFI1TEMg QlRZV2RoSU ZCeSBaV1ps WTNSMWNtIF VzSUVwaGNH RnUgTENCaG JtUWdhRyBG eklHOTJaWE lnIE55d3dN REFnWlcgMX diRzk1WldW eiBManhpY2 o0MUxpIEJJ YVhOaGJXbD AgYzNVZ1VH aGhjbSAxaF kyVjFkR2xq IFlXd2dhR0 Z6SUcgRWdi Rzl1WnlCby BhWE4wYjNK NUxDIEIzYV hSb0lHOTIg WlhJZ01UY3 dJSCBsbFlY SnpJRzltIE lHVjRjR1Z5 YVcgVnVZMl VnYVc0ZyBk R2hsSUhCb1 lYIEp0WVdO bGRYUnAgWT JGc0lHbHVa SCBWemRISj VManhpIGNq NDJMaUJVYU cgVWdZMjl0 Y0dGdSBlU0 JvWVhNZ1lT IEJ6ZEhKdm JtY2cgWm05 amRYTWdiMi A0Z2NtVnpa V0Z5IFkyZ2 dZVzVrSUcg UmxkbVZzYj NCdCBaVzUw TENCM2FYIF JvSUdGd2NI SnYgZUdsdF lYUmxiSCBr Z01Td3dNRE FnIFpXMXdi Rzk1WlcgVn pJR1JsWkds aiBZWFJsWk NCMGJ5IEJT SmtRdVBHSn kgUGpjdUlF aHBjMiBGdG FYUnpkU0Jw IGN5QnZibV VnYjIgWWdk R2hsSUdabC BkeUJqYjIx d1lXIDVwWl hNZ2FXNGcg U21Gd1lXNG dkRyBoaGRD Qm9ZWE1nIF lTQmpiMjF3 Y20gVm9aVz V6YVhabCBJ R2x1TFdodm RYIE5sSUhC eWIyUjEgWT NScGIyNGdj MyBsemRHVn RMQ0JtIGNt OXRJSEJ5Yj IgUjFZM1Fn WkdWMiBaV3 h2Y0cxbGJu IFFnZEc4Z2 JXRnUgZFda aFkzUjFjbS BsdVp5Qmhi bVFnIFpHbH pkSEpwWW4g VjBhVzl1TG p4aSBjajQ0 TGlCVWFHIF VnWTI5dGNH RnUgZVNCb1 lYTWdZUyBC bmJHOWlZV3 dnIGNISmxj MlZ1WTIgVX NJSGRwZEdn ZyBjM1ZpYz Jsa2FXIEZ5 YVdWeklHRn UgWkNCaFpt WnBiRyBsaG RHVnpJR2x1 IElIUm9aU0 JWYm0gbDBa V1FnVTNSaC BkR1Z6TENC RmRYIEp2Y0 dVc0lHRnUg WkNCQmMybG hMaiB4aWNq NDVMaUJKIG JpQmhaR1Jw ZEcgbHZiaU IwYnlCcCBk SE1nY0doaG NtIDFoWTJW MWRHbGogWV d3Z2NISnZa SCBWamRITX NJRWhwIGMy RnRhWFJ6ZF MgQmhiSE52 SUc5bSBabV Z5Y3lCd1pY IEp6YjI1aG JDQmogWVhK bElHRnVaQy BCb1pXRnNk R2dnIGNISn ZaSFZqZEgg TXNJSE4xWT JnZyBZWE1n WlhsbElHIE 5oY21VZ1lX NWsgSUhOcm FXNWpZWCBK bElIQnliMl IxIFkzUnpM anhpY2ogNH hNQzRnU0ds eiBZVzFwZE hOMUlHIGho Y3lCaElITj AgY205dVp5 QmpiMiAxdG FYUnRaVzUw IElIUnZJSE 4xYzMgUmhh VzVoWW1scy BhWFI1SUdG dVpDIEJvWV hNZ2FXMXcg YkdWdFpXNT BaVyBRZ2Rt RnlhVzkxIG N5Qmxiblpw Y20gOXViV1 Z1ZEdGcyBJ R2x1YVhScF lYIFJwZG1W ekxDQnogZF dOb0lHRnpJ SCBKbFpIVm phVzVuIElI ZGhjM1JsSU cgRnVaQ0J3 Y205dCBiM1 JwYm1jZ2Nt IFZ1WlhkaF lteGwgSUdW dVpYSm5lUy A0OFluSStN VEV1IElGUm 9aU0JqYjIg MXdZVzU1SU doaCBjeUJo SUhOMGNtID l1WnlCbWIy TjEgY3lCdm JpQmpiMyBK d2IzSmhkR1 VnIGMyOWph V0ZzSUggSm xjM0J2Ym5O cCBZbWxzYV hSNUxDIEIz YVhSb0lHbH UgYVhScFlY UnBkbSBWek lIUnZJSE4x IGNIQnZjbl FnZEcgaGxJ R052YlcxMS BibWwwZVNC aGJtIFFnY0 hKdmJXOTAg WlNCbGJYQn NiMyBsbFpT Qm9aV0ZzIG RHZ2dZVzVr SUggZGxiR3 d0WW1WcCBi bWN1UEdKeV BqIEV5TGlC SWFYTmggYl dsMGMzVWdk MiBGeklISm xZMjluIGJt bDZaV1FnWV ggTWdiMjVs SUc5bSBJSF JvWlNCQ1pY IE4wSUVOdm JYQmggYm1s bGN5QjBieS BCWGIzSnJJ R1p2IGNpQn BiaUJLWVgg QmhiaUJtYj NJZyBkR2h5 WldVZ1kyID l1YzJWamRY UnAgZG1VZ2 VXVmhjbiBN Z1puSnZiU0 F5IE1ERXpJ SFJ2SUQgSX dNVFV1UEdK eSBQakV6TG lCSWFYIE5o YldsMGMzWG kgZ0pseklH TnZjbiBCdm NtRjBaU0J3 IGFHbHNiM0 52Y0cgaDVJ R2x6SUVOby BZV3hzWlc1 bmFXIDVuSU hSdklHSmwg SUZWdWFYRj FaUyB3Z1pX MXdhR0Z6IG FYcHBibWNn YVcgNXViM1 poZEdsdiBi aXdnWTNKbF lYIFJwZG1s MGVTd2cgWV c1a0lIVnVh WCBGMVpXNW xjM01nIGFX NGdhWFJ6SU ggQnliMlIx WTNSeiBJR0 Z1WkNCelpY IEoyYVdObG N5ND0KICAg ICAgICA8L3 NwYW4+CiAg ICAgICAgCi AgICAgICAg
See Company Q&A
Hisamitsu Pharmaceutical

πŸ“Š Get full analytics about Hisamitsu Pharmaceutical

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal